Geynisman, D. M., Abbosh, P. H., Ross, E., Zibelman, M. R., Ghatalia, P., Anari, F., Mark, J. R., Stamatakis, L., Hoffman-Censits, J. H., Viterbo, R., Greenberg, R. E., Churilla, T. M., Horwitz, E. M., Hallman, M. A., Smaldone, M. C., Uzzo, R., Chen, D. Y., Kutikov, A., Plimack, E. R. (2025). Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1). Journal of Clinical Oncology. https://doi.org/10.1200/jco-24-01214